Related Experiment Video

Updated: May 4, 2026

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

4.7K

Plasma-derived medicinal products in Italy: information sources and flows

Monica Lanzoni1, Claudia Biffoli2, Fabio Candura3

  • 1Italian National Blood Centre, National Institute of Health, Rome, Italy IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.

Blood Transfusion = Trasfusione Del Sangue
|December 17, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

1.8K
Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

6.1K

Related Experiment Videos

Last Updated: May 4, 2026

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

4.7K
Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

1.8K
Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

6.1K

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

369
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
369
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

430
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
430

Articles linked to this work by shared authors, journal, and citation graph.

Prevalence and Cure of Primary Liver Cancer in Italy by Histologic Type.

Cancers·2026

Organizational monitoring of patient blood management implementation: Results of an Italian national survey.

Vox sanguinis·2026

A validation study of the in vitro performance of hypoxic red blood cells for transfusion across centers in Europe.

Transfusion·2025

Outbreak of autochthonous West Nile virus infection in Lazio region, Italy, July to August 2025: preliminary investigation.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025

Comprehensive analysis of parvovirus B19 infection in blood donors: epidemiological trend and implications for transfusion safety and management strategies in Italy.

Blood transfusion = Trasfusione del sangue·2025

Securing commitment and control for the supply of plasma derivatives for public health systems. I: A short review of the global landscape.

Vox sanguinis·2024

Perceived risk explains aversion to blood donation by men who have sex with men.

Blood transfusion = Trasfusione del sangue·2026

Salvianolic acid B alleviates red blood cell storage lesion with GPX4 preservation and reduced lipid peroxidation.

Blood transfusion = Trasfusione del sangue·2026

Standardized diagnostic approach for cold agglutinin disease: results from a Delphi-Based Expert Consensus.

Blood transfusion = Trasfusione del sangue·2026

Distribution of human platelet antigen genotypes in Lithuanian blood donors.

Blood transfusion = Trasfusione del sangue·2026

RBCs of Asian-type DEL do not undergo antibody-mediated phagocytosis by macrophages.

Blood transfusion = Trasfusione del sangue·2026

Blood donor deferral patterns in Iran: six-year national analysis (2016-2021).

Blood transfusion = Trasfusione del sangue·2026

Trustworthy AI-Powered Intrusion Detection for the Internet of Medical Things (IoMT): A Review.

Sensors (Basel, Switzerland)·2026

A protection strategy for distribution networks using IoT technology and support vector machine.

Scientific reports·2026

ICU Open-Access Databases for Artificial Intelligence in Sepsis: Balancing Innovation With Data Quality Challenges.

Critical care medicine·2026

From digital twins to clinically trustworthy twins: a clinical-claim-based validation framework for personalized digital health.

Frontiers in digital health·2026

Multimodal Benchmark for Safety Assessment in Industrial Inspection Scenarios.

Scientific data·2026

Reservoir computing for network intrusion classification.

PloS one·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us